Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lynch

Showing results (851-860 of 929) with videos related to

Pageof 93
Sort By:
European Journal of Neurology|December 17, 2010
SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction studyC Wider, C Vilariño-Güell, M G Heckman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control studyAndrea Eisen, Jan Lubinski, Jan Klijn, et al.
International Journal of Epidemiology|March 17, 2018
Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriersShana J Kim, Tomasz Huzarski, Jacek Gronwald, et al.
European Journal of Neurology|August 14, 2009
Calbindin-1 association and Parkinson's diseaseA I Soto-Ortolaza, B Behrouz, C Wider, et al.
British Journal of Cancer|December 3, 2013
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up studyC M Phelan, J Iqbal, H T Lynch, et al.
Breast Cancer Research : BCR|March 13, 2012
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Leonardo Salmena, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutationsAlfonso Bellacosa, Andrew K Godwin, Suraj Peri, et al.
JACC. Clinical Electrophysiology|July 18, 2024
Mortality in Recipients of Durable Left Ventricular Assist Devices Undergoing Ventricular Tachycardia AblationPatrick T Lynch, Alexandra Maloof, Anish Badjatiya, et al.
Journal of the National Cancer Institute|September 8, 2016
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersJoanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, et al.
Oncogene|October 14, 2022
AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitorsShanade Dunn, Cath Eberlein, Jason Yu, et al.
Pageof 93

Showing results (851-860 of 929) with videos related to

Sort By:
Pageof 93
European Journal of Neurology|December 17, 2010
SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction studyC Wider, C Vilariño-Güell, M G Heckman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control studyAndrea Eisen, Jan Lubinski, Jan Klijn, et al.
International Journal of Epidemiology|March 17, 2018
Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriersShana J Kim, Tomasz Huzarski, Jacek Gronwald, et al.
European Journal of Neurology|August 14, 2009
Calbindin-1 association and Parkinson's diseaseA I Soto-Ortolaza, B Behrouz, C Wider, et al.
British Journal of Cancer|December 3, 2013
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up studyC M Phelan, J Iqbal, H T Lynch, et al.
Breast Cancer Research : BCR|March 13, 2012
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Leonardo Salmena, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutationsAlfonso Bellacosa, Andrew K Godwin, Suraj Peri, et al.
JACC. Clinical Electrophysiology|July 18, 2024
Mortality in Recipients of Durable Left Ventricular Assist Devices Undergoing Ventricular Tachycardia AblationPatrick T Lynch, Alexandra Maloof, Anish Badjatiya, et al.
Journal of the National Cancer Institute|September 8, 2016
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersJoanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, et al.
Oncogene|October 14, 2022
AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitorsShanade Dunn, Cath Eberlein, Jason Yu, et al.
Pageof 93